Biography:
Dr. Suman Verma has earned her Ph.D. in molecular biology and completed postdoctoral fellowship from University of California, Irvine, USA, where she performed and published research on breast cancer biology. Currently, Dr. Verma serves as a Chief Scientific Officer of Lucid Diagnostics, Inc. a publicly traded cancer prevention medical diagnostics company. Her research is focused on development of molecular diagnostic tests for detection of Barrett’s Esophagus and EAC. Prior to joining Lucid Diagnostics, she has served in various scientific and senior executive roles where she led the development and implementation of numerous molecular diagnostic tests and published several research articles.
Title : Methylation based biomarker test in combination with non-invasive cell collection device for detection of barrett's esophagus and esophageal adenocarcinoma